GLOW 70mg

Description

DESCRIPTION

GLOW 70mg is a multi-component research blend combining GHK-Cu, BPC-157, and TB-500 (TB4 fragment) supplied as a lyophilized powder for in vitro and laboratory research applications. The constituent peptides are studied for their distinct molecular interactions: GHK-Cu functions as a copper-binding tripeptide that participates in metal-ion coordination and modulation of gene-expression pathways associated with extracellular matrix proteins; BPC-157 is a pentadecapeptide investigated for its interaction with growth-factor signaling and angiogenic pathway components; and the TB-500 fragment is examined for its role in actin-binding dynamics and cytoskeletal regulation. This blend is intended solely as a reference material for characterizing combined peptide chemistry and receptor- and pathway-level mechanisms in controlled experimental models.

RESEARCH AREAS

• Copper-ion coordination chemistry and matrix metalloproteinase pathway modulation attributed to the GHK-Cu component
• Actin sequestration and cytoskeletal polymerization dynamics associated with the TB-500 fragment
• Growth-factor and angiogenic signaling pathway interactions studied in relation to the BPC-157 component
• Multi-peptide combinatorial chemistry and comparative pathway-level behavior of co-formulated sequences

WHAT RESEARCHERS LOOK AT

• Reconstitution stability and solubility profiling of each component via HPLC and mass spectrometry
• Quantification of relative peptide ratios and purity using analytical chromatography methods
• Receptor-binding and pathway-activation assays conducted in defined cell-culture models
• Comparative analysis of single-peptide versus blended-peptide behavior under controlled in vitro conditions

QUICK SPECS

• Form: Lyophilized powder
• Net per vial: 70mg total blend (GHK-Cu / BPC-157 / TB-500)
• Purity: ≥99% (HPLC, per component)
• Identity: Confirmed by mass spectrometry
• Storage: Lyophilized at -20°C; reconstituted, refrigerate at 2–8°C and protect from light

IDENTITY BASICS

• Type: Multi-peptide research blend (tripeptide-copper complex + pentadecapeptide + actin-binding fragment)
• Sequence/Formula: GHK-Cu (Gly-His-Lys·Cu); BPC-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val); TB-500 (Ac-LKKTETQ)
• Molecular weight: GHK-Cu ≈ 403.9 g/mol; BPC-157 ≈ 1419.5 g/mol; TB-500 fragment ≈ 889.0 g/mol
• CAS: GHK-Cu 89030-95-5; BPC-157 137525-51-0; TB-500 (Tβ4 1-4 fragment) 885340-08-9

SELECTED RESEARCH

• GHK peptide and copper coordination — tissue remodeling pathways (PubMed)
• BPC-157 and angiogenic/growth-factor signaling (PubMed)
• Thymosin β4 actin-binding and cytoskeletal dynamics (PubMed)
• GHK-Cu chemical and structural data (PubChem)

⚠️ DISCLAIMER

• For laboratory and in vitro research use only — not for human or veterinary use.
• Not a drug, food, dietary supplement, or cosmetic; not intended to diagnose, treat, cure, or prevent any condition.
• Handling restricted to qualified research personnel in an appropriate laboratory setting.
• Not approved by the FDA for any therapeutic or clinical application.